|
The GenetownTM Hotbed community highlights the organizations that comprise the biotechnology, pharmaceutical and medical device industries in Massachusetts. The Genetown Hotbed Map is printed on thousands of promotional pieces and distributed at major life science events and career fairs throughout the annual campaign, while the Genetown Hotbed Page keeps the BioSpace audience informed of the daily activities and events throughout the region. |
 |
feed of the 100 most recent jobs
|
|
Hotbed News |
Stryker Biotech And Its Top Management Indicted For Illegal Promotion Of Medical Devices Used In Invasive Surgeries
Friday, November 20, 2009
More...
|
Cambridge-based Ligon Discovery Raises $1M in Seed Funding
Friday, November 20, 2009
More...
|
FDA Approves Gloucester Pharmaceuticals, Inc.'s ISTODAX(R) for Patients with Cutaneous T-cell Lymphoma
Friday, November 20, 2009
More...
|
RXi Pharmaceuticals (RXII) Appoints Noah D. Beerman as CEO
Friday, November 20, 2009
More...
|
Altus Pharmaceuticals Inc. (ALTU) Files for Chapter 7 Bankruptcy
Friday, November 20, 2009
More...
|
Paloma Pharmaceuticals, Inc. Presents at the Association for Research in Vision & Ophthalmology 2009 Meeting
Friday, November 20, 2009
More...
|
Paloma Pharmaceuticals, Inc. presents at the 10th International Symposium on Antiangiogenic Agents
Friday, November 20, 2009
More...
|
Paloma Pharmaceuticals, Inc. Published Paper in British Journal of Cancer
Friday, November 20, 2009
More...
|
Elixir Pharmaceuticals Signs Option Agreement with a Major Pharmaceutical Company, Novartis Corporation (NVS); Deal Could Exceed $500 Million, Completes $12M Equity Financing
Friday, November 20, 2009
More...
|
Boston Scientific Corporation (BSX) (JOBS) Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent
Friday, November 20, 2009
More...
|
|
|
|
Hotbed Events |
Monitoring Clinical Drug Studies: Advanced
Tuesday, December 01, 2009
-
Wednesday, December 02, 2009
|
Drug Development & FDA Regulations
Tuesday, December 01, 2009
-
Wednesday, December 02, 2009
|
Conducting Clinical Trials in Developing Regions
Tuesday, December 01, 2009
-
Wednesday, December 02, 2009
|
Clinical Project Management: Intermediate
Tuesday, December 01, 2009
-
Wednesday, December 02, 2009
|
DBA Quality Leadership Program - Medicinal Chemistry and Therapeutics
Monday, November 30, 2009
-
Wednesday, December 02, 2009
|
The New England Venture Summit - Where Innovation Meets Capital
Tuesday, December 08, 2009
-
Tuesday, December 08, 2009
|
Working with CROs
Tuesday, December 08, 2009
-
Wednesday, December 09, 2009
|
Monitoring Clinical Drug Studies: Intermediate
Tuesday, December 08, 2009
-
Wednesday, December 09, 2009
|
Fraud in Clinical Research
Tuesday, December 08, 2009
-
Wednesday, December 09, 2009
|
CRA & CRC Beginner
Wednesday, December 09, 2009
-
Friday, December 11, 2009
|
|
|
|
|
Hotbed Participants |
| Abbott Bioresearch Center |
| Adnexus, A Bristol-Myers Squibb R&D Company |
| Advanced Technologies and Regenerative Medicine, LLC (ATRM) |
| Alkermes |
| Alnylam Pharmaceuticals |
| Associates of Cape Cod, Inc. |
| Avecia Biotechnology Inc. |
| Averion International Corp. |
| Babson Executive Education |
| Baxter International Inc. and Technology Resources |
| Bristol-Myers Squibb Company |
| Broad Institute |
| CombinatoRx, Incorporated |
| Dana-Farber Cancer Institute |
| Dyax Corp. |
| FoldRx Pharmaceuticals, Inc. |
| Genzyme Corporation |
| i3 (Newton, Massachusetts) |
| Idenix Pharmaceuticals, Inc. |
| Idera Pharmaceuticals, Inc. |
| Infinity Pharmaceuticals, Inc. |
| Johnson Matthey Pharma Services |
| Lantheus Medical Imaging |
| Lonza Biologics Inc. |
| Massachusetts Biotechnology Council, Inc. |
| Merck Research Laboratories Boston |
| Millennium: The Takeda Oncology Company |
| Millipore Corporation |
| Momenta Pharmaceuticals, Inc. |
| New England Biolabs, Inc. |
| Novartis Institutes for BioMedical Research |
| Pfizer Research Technology Center (RTC) |
| Randstad |
| Sanofi Pasteur Biologics Co. |
| Sanofi-Aventis (Massachusetts) |
| The Richmond Group |
| Tolerx, Inc. |
| Toxikon Corporation |
| TransForm Pharmaceuticals, Inc. |
| Verenium Corporation |
| Vertex Pharmaceuticals Incorporated |
| Wyeth Biotech (Massachusetts) |
|
|